Immunovant Inc
NASDAQ:IMVT
Income Statement
Earnings Waterfall
Immunovant Inc
Revenue
|
0
USD
|
Operating Expenses
|
-253.6m
USD
|
Operating Income
|
-253.6m
USD
|
Other Expenses
|
10.1m
USD
|
Net Income
|
-243.4m
USD
|
Income Statement
Immunovant Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(46)
|
(66)
|
(59)
|
(79)
|
(100)
|
(108)
|
(111)
|
(128)
|
(138)
|
(156)
|
(167)
|
(178)
|
(191)
|
(208)
|
(234)
|
(246)
|
(254)
|
|
Selling, General & Administrative |
(6)
|
(18)
|
(22)
|
(31)
|
(36)
|
(40)
|
(41)
|
(48)
|
(49)
|
(54)
|
(55)
|
(51)
|
(51)
|
(48)
|
(51)
|
(53)
|
(55)
|
|
Research & Development |
(5)
|
(48)
|
(36)
|
(48)
|
(64)
|
(69)
|
(70)
|
(80)
|
(88)
|
(102)
|
(112)
|
(128)
|
(140)
|
(160)
|
(182)
|
(193)
|
(199)
|
|
Other Operating Expenses |
(35)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(46)
N/A
|
(66)
-44%
|
(59)
+11%
|
(79)
-35%
|
(100)
-26%
|
(108)
-8%
|
(111)
-3%
|
(128)
-15%
|
(138)
-8%
|
(156)
-13%
|
(167)
-7%
|
(178)
-7%
|
(191)
-7%
|
(208)
-9%
|
(234)
-12%
|
(246)
-5%
|
(254)
-3%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
0
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
8
|
12
|
14
|
20
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(23)
|
(23)
|
(13)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
0
|
1
|
(1)
|
(0)
|
(0)
|
(1)
|
2
|
|
Pre-Tax Income |
(45)
N/A
|
(66)
-46%
|
(58)
+12%
|
(79)
-36%
|
(100)
-26%
|
(108)
-8%
|
(112)
-4%
|
(129)
-15%
|
(138)
-7%
|
(157)
-14%
|
(166)
-6%
|
(176)
-6%
|
(198)
-12%
|
(211)
-7%
|
(245)
-16%
|
(255)
-4%
|
(244)
+4%
|
|
Net Income | ||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
1
|
|
Income from Continuing Operations |
(46)
|
(66)
|
(58)
|
(79)
|
(100)
|
(107)
|
(111)
|
(128)
|
(138)
|
(157)
|
(167)
|
(177)
|
(199)
|
(211)
|
(245)
|
(255)
|
(243)
|
|
Net Income (Common) |
(46)
N/A
|
(66)
-45%
|
(58)
+12%
|
(79)
-36%
|
(100)
-26%
|
(107)
-8%
|
(111)
-4%
|
(128)
-15%
|
(138)
-8%
|
(157)
-14%
|
(167)
-6%
|
(177)
-6%
|
(199)
-12%
|
(211)
-6%
|
(245)
-16%
|
(255)
-4%
|
(243)
+5%
|
|
EPS (Diluted) |
-1.13
N/A
|
-1.54
-36%
|
-0.82
+47%
|
-0.94
-15%
|
-1.01
-7%
|
-1.22
-21%
|
-1.13
+7%
|
-1.17
-4%
|
-1.19
-2%
|
-1.43
-20%
|
-1.42
+1%
|
-1.53
-8%
|
-1.54
-1%
|
-1.71
-11%
|
-1.87
-9%
|
-1.94
-4%
|
-1.68
+13%
|